albendazole has been researched along with Meningitis in 33 studies
Meningitis: Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine how combination therapy with albendazole and dexamethasone changed cytokine responses in peripheral blood mononuclear cells (PBMC) in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis (EOMA), we measured mRNA levels of Th2 (IL-5, IL-4 and IL-10) and Th1 (IL-2 and IFN-gamma) cytokines with reverse transcription polymerase chain reaction (RT-PCR)." | 7.75 | Angiostrongylus cantonensis: effect of combination therapy with albendazole and dexamethasone on Th cytokine gene expression in PBMC from patients with eosinophilic meningitis. ( Chen, X; Diao, Z; Ji, A; Qi, H; Wang, J; Yin, C, 2009) |
| "To evaluate the curative effect of albendazole/thalidomide co-therapy on eosinophilic meningitis in BALB/c mice caused by Angiostrongylus cantonensis." | 7.74 | Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. ( Chen, KM; Lai, SC, 2007) |
| "The effects of albendazole and Yin-Chen-Extract co-therapy on Angiostrongylus cantonensis-induced eosinophilic meningitis in BALB/c mice were evaluated." | 7.73 | Chinese herbal medicine Yin-Chen-Extract as an adjunct to anthelmintic albendazole used against Angiostrongylus cantonensis-induced eosinophilic meningitis or meningoencephalitis. ( Lai, SC, 2006) |
| "Albendazole was administered at 15 mg/kg/day or identical placebo for 2 weeks." | 6.73 | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. ( Jitpimolmard, S; Korwanich, N; Morakote, N; Puntumetakul, M; Sanchaisuriya, K; Sawanyawisuth, K; Tassaneeyakul, W; Vejjajiva, A, 2007) |
| " To evaluate the efficacy of albendazole combined with a marine fungal extract (m2-9) in A." | 5.38 | Efficacy of albendazole combined with a marine fungal extract (m2-9) against Angiostrongylus cantonensis-induced meningitis in mice. ( He, HJ; Li, J; Li, ZY; Lin, YC; Lv, ZY; Song, YX; Sun, R; Wei, J; Wu, ZD; Yang, F; Zeng, X; Zheng, HQ, 2012) |
| "Baicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi." | 5.37 | Efficacy of combined treatment with albendazole and baicalein against eosinophilic meningitis induced by Angiostrongylus cantonensis in mice. ( He, HJ; Li, ZY; Liao, Q; Lv, ZY; Rao, SQ; Su, WY; Wu, ZD; Yu, XB; Zhang, LY; Zheng, HQ, 2011) |
| " At the same dosage and days post-infection, the earlier administration shows better results." | 5.33 | Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis. ( Lai, SC; Tu, WC, 2006) |
| "To determine how combination therapy with albendazole and dexamethasone changed cytokine responses in peripheral blood mononuclear cells (PBMC) in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis (EOMA), we measured mRNA levels of Th2 (IL-5, IL-4 and IL-10) and Th1 (IL-2 and IFN-gamma) cytokines with reverse transcription polymerase chain reaction (RT-PCR)." | 3.75 | Angiostrongylus cantonensis: effect of combination therapy with albendazole and dexamethasone on Th cytokine gene expression in PBMC from patients with eosinophilic meningitis. ( Chen, X; Diao, Z; Ji, A; Qi, H; Wang, J; Yin, C, 2009) |
| "To evaluate the curative effect of albendazole/thalidomide co-therapy on eosinophilic meningitis in BALB/c mice caused by Angiostrongylus cantonensis." | 3.74 | Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. ( Chen, KM; Lai, SC, 2007) |
| "The effects of albendazole and Yin-Chen-Extract co-therapy on Angiostrongylus cantonensis-induced eosinophilic meningitis in BALB/c mice were evaluated." | 3.73 | Chinese herbal medicine Yin-Chen-Extract as an adjunct to anthelmintic albendazole used against Angiostrongylus cantonensis-induced eosinophilic meningitis or meningoencephalitis. ( Lai, SC, 2006) |
| "Albendazole was administered at 15 mg/kg/day or identical placebo for 2 weeks." | 2.73 | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. ( Jitpimolmard, S; Korwanich, N; Morakote, N; Puntumetakul, M; Sanchaisuriya, K; Sawanyawisuth, K; Tassaneeyakul, W; Vejjajiva, A, 2007) |
| " We recommend combined therapy with albendazole and prednisolone, with consideration for increased steroid dosing in severe cases." | 2.61 | Severe CNS angiostrongyliasis in a young marine: a case report and literature review. ( Bavaro, M; Cathey, M; Fortin Ensign, S; Larson, D; McAuliffe, L; Mukaigawara, M; Narita, M; Ohkusu, K; Quast, T; Volk, C; Yetto, J, 2019) |
| "All patients presented with hydrocephalus and/or meningitis." | 2.41 | Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. ( Andrews, RJ; Cuetter, AC, 2002) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| "Sepsis and meningitis are frequent." | 2.38 | [Systemic strongyloidiasis. Review]. ( Chacín-Bonilla, L, 1991) |
| "A." | 1.46 | Angiostrongylus cantonensis Meningitis and Myelitis, Texas, USA. ( Al Hammoud, R; Butler, IJ; Heresi, GP; Murphy, JR; Nayes, SL; Pérez, N, 2017) |
| " To evaluate the efficacy of albendazole combined with a marine fungal extract (m2-9) in A." | 1.38 | Efficacy of albendazole combined with a marine fungal extract (m2-9) against Angiostrongylus cantonensis-induced meningitis in mice. ( He, HJ; Li, J; Li, ZY; Lin, YC; Lv, ZY; Song, YX; Sun, R; Wei, J; Wu, ZD; Yang, F; Zeng, X; Zheng, HQ, 2012) |
| "Baicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi." | 1.37 | Efficacy of combined treatment with albendazole and baicalein against eosinophilic meningitis induced by Angiostrongylus cantonensis in mice. ( He, HJ; Li, ZY; Liao, Q; Lv, ZY; Rao, SQ; Su, WY; Wu, ZD; Yu, XB; Zhang, LY; Zheng, HQ, 2011) |
| "Eosinophilic meningitis is an uncommon clinical entity, which is mostly caused by Angiostrongylus cantonensis, a nematode which parasitizes rat's lungs." | 1.35 | [Two outbreaks of eosinophilic meningitis in Yunann (China) clinical, epidemiological and therapeutical issues]. ( Barennes, H; Ding, L; Strobel, M; Zhou, N; Zhou, Z; Zhu, YH, 2009) |
| " At the same dosage and days post-infection, the earlier administration shows better results." | 1.33 | Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis. ( Lai, SC; Tu, WC, 2006) |
| "Headache, paresthesias and the finding of an eosinophilic meningitis in patients returning from tropical or subtropical regions should lead to the suspicion and eventually the treatment of an Angiostrongyliasis." | 1.33 | [Headache after a stay in the Dominican Republic]. ( Bialek, R; Lindner, A; Rau, C; Richter, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 16 (48.48) | 29.6817 |
| 2010's | 11 (33.33) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Jhan, KY | 1 |
| Cheng, CJ | 1 |
| Chou, CJ | 1 |
| Jung, SM | 2 |
| Lai, GJ | 1 |
| Chen, KY | 1 |
| Wang, LC | 2 |
| Qiu, G | 1 |
| Zhu, L | 1 |
| Chen, S | 1 |
| Li, N | 1 |
| Ye, C | 1 |
| Zhuo, S | 1 |
| Shen, Y | 1 |
| Al Hammoud, R | 1 |
| Nayes, SL | 1 |
| Murphy, JR | 1 |
| Heresi, GP | 1 |
| Butler, IJ | 1 |
| Pérez, N | 1 |
| Nguyen, Y | 1 |
| Rossi, B | 1 |
| Argy, N | 1 |
| Baker, C | 1 |
| Nickel, B | 1 |
| Marti, H | 1 |
| Zarrouk, V | 1 |
| Houzé, S | 1 |
| Fantin, B | 1 |
| Lefort, A | 1 |
| McAuliffe, L | 1 |
| Fortin Ensign, S | 1 |
| Larson, D | 1 |
| Bavaro, M | 1 |
| Yetto, J | 1 |
| Cathey, M | 1 |
| Mukaigawara, M | 1 |
| Narita, M | 1 |
| Ohkusu, K | 1 |
| Quast, T | 1 |
| Volk, C | 1 |
| Balkhair, A | 1 |
| Taher, HB | 1 |
| Al Busaidi, I | 1 |
| Al Amin, M | 1 |
| Al-Khirbash, A | 1 |
| Al Adawi, B | 1 |
| Al-Siyabi, T | 1 |
| Yang, B | 1 |
| Yang, L | 1 |
| Chen, Y | 1 |
| Lu, G | 1 |
| Khan, TT | 1 |
| Elzein, F | 1 |
| Fiaar, A | 1 |
| Akhtar, F | 1 |
| Lammers, AJ | 1 |
| Goorhuis, A | 1 |
| van de Beek, D | 1 |
| Grobusch, MP | 1 |
| Bart, A | 1 |
| van Gool, T | 1 |
| van Vugt, M | 1 |
| Malvy, D | 1 |
| Ezzedine, K | 1 |
| Receveur, MC | 1 |
| Pistone, T | 1 |
| Crevon, L | 1 |
| Lemardeley, P | 1 |
| Josse, R | 1 |
| Diao, Z | 1 |
| Chen, X | 1 |
| Yin, C | 1 |
| Wang, J | 1 |
| Qi, H | 1 |
| Ji, A | 1 |
| Zhou, Z | 1 |
| Barennes, H | 1 |
| Zhou, N | 1 |
| Ding, L | 1 |
| Zhu, YH | 1 |
| Strobel, M | 1 |
| Chotmongkol, V | 1 |
| Kittimongkolma, S | 1 |
| Niwattayakul, K | 1 |
| Intapan, PM | 1 |
| Thavornpitak, Y | 1 |
| He, HJ | 2 |
| Lv, ZY | 2 |
| Li, ZY | 2 |
| Zhang, LY | 1 |
| Liao, Q | 1 |
| Zheng, HQ | 2 |
| Su, WY | 1 |
| Rao, SQ | 1 |
| Yu, XB | 1 |
| Wu, ZD | 2 |
| Sun, R | 1 |
| Li, J | 1 |
| Song, YX | 1 |
| Lin, YC | 1 |
| Zeng, X | 1 |
| Wei, J | 1 |
| Yang, F | 1 |
| Shyu, LY | 2 |
| Chang, HH | 1 |
| Hsu, JD | 3 |
| Lin, DP | 1 |
| Teng, YH | 1 |
| Lee, HH | 3 |
| Li, Y | 1 |
| Tang, JP | 1 |
| Chen, DR | 1 |
| Fu, CY | 1 |
| Wang, P | 1 |
| Li, Z | 1 |
| Wei, W | 1 |
| Li, H | 1 |
| Dong, WQ | 1 |
| Lan, KP | 1 |
| Wang, CJ | 1 |
| Lai, SC | 5 |
| Chen, KM | 3 |
| Lee, SS | 1 |
| Jiang, ST | 1 |
| Cuetter, AC | 1 |
| Andrews, RJ | 1 |
| Castillo-Iglesias, H | 1 |
| Mouly, S | 1 |
| Ducros, A | 1 |
| Sarfati, C | 1 |
| Sulahian, A | 1 |
| Bergmann, JF | 1 |
| Chen, CC | 1 |
| Wong, HF | 1 |
| Wan, DP | 1 |
| Wan, YL | 1 |
| Tu, WC | 1 |
| Rau, C | 1 |
| Bialek, R | 1 |
| Richter, S | 1 |
| Lindner, A | 1 |
| Jitpimolmard, S | 1 |
| Sawanyawisuth, K | 1 |
| Morakote, N | 1 |
| Vejjajiva, A | 1 |
| Puntumetakul, M | 1 |
| Sanchaisuriya, K | 1 |
| Tassaneeyakul, W | 2 |
| Korwanich, N | 1 |
| Pai, PJ | 1 |
| Blackburn, BG | 1 |
| Kazacos, KR | 1 |
| Warrier, RP | 1 |
| Bégué, RE | 1 |
| Baheti, NN | 1 |
| Sreedharan, M | 1 |
| Krishnamoorthy, T | 1 |
| Nair, MD | 1 |
| Radhakrishnan, K | 1 |
| La Mantia, L | 1 |
| Costa, A | 1 |
| Eoli, M | 1 |
| Savoiardo, M | 1 |
| Rajadhyaksha, AG | 1 |
| Anil, CR | 1 |
| Tilve, GH | 1 |
| Overbosch, D | 1 |
| Chacín-Bonilla, L | 1 |
4 reviews available for albendazole and Meningitis
| Article | Year |
|---|---|
Severe CNS angiostrongyliasis in a young marine: a case report and literature review.
Topics: Adrenal Cortex Hormones; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Diagnosis | 2019 |
Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Cerebral Ventricles; Diagnosis, Differential; F | 2002 |
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
[Systemic strongyloidiasis. Review].
Topics: Albendazole; Animals; Disease Susceptibility; Humans; Immunocompromised Host; Intestinal Diseases, P | 1991 |
2 trials available for albendazole and Meningitis
| Article | Year |
|---|---|
Comparison of prednisolone plus albendazole with prednisolone alone for treatment of patients with eosinophilic meningitis.
Topics: Adolescent; Adult; Aged; Albendazole; Angiostrongylus cantonensis; Animals; Anti-Inflammatory Agents | 2009 |
Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis.
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Double-Blind Method; Female | 2007 |
27 other studies available for albendazole and Meningitis
| Article | Year |
|---|---|
Improvements of cognitive functions in mice heavily infected by Angiostrongylus cantonensis after treatment with albendazole, dexamethasone, or co-therapy.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Cognition; Dexamethasone; Humans; | 2022 |
High-throughput metagenomics analysis in early and precise diagnosis of eosinophilic meningoencephalitis complicated with respiratory failure: A case report.
Topics: Aftercare; Aged; Albendazole; Angiostrongylus cantonensis; Animals; Antibodies; Female; Humans; Meni | 2023 |
Angiostrongylus cantonensis Meningitis and Myelitis, Texas, USA.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Antibodies, Helminth; Child; Femal | 2017 |
Autochthonous Case of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, France, 2016.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Antigens, Helminth; Eosinophilia; | 2017 |
Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin.
Topics: Albendazole; Animals; Anthelmintics; Hemorrhage; Humans; Ivermectin; Male; Meningitis; Middle Aged; | 2019 |
Magnetic resonance imaging findings and clinical manifestations in cerebral angiostrongyliasis from Dali, China.
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Brain; China; Eosinophilia; | 2019 |
Recurrent Streptococcus bovis meningitis in Strongyloides stercoralis hyperinfection after kidney transplantation: the dilemma in a non-endemic area.
Topics: Adult; Albendazole; Dexamethasone; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidne | 2014 |
Eosinophilia à deux: a brain nagging souvenir from the Philippines.
Topics: Adrenal Cortex Hormones; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Anti-Infl | 2015 |
Cluster of eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in French policemen troop returning from the Pacific Islands.
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Cohort Studies; Eosinophili | 2008 |
Angiostrongylus cantonensis: effect of combination therapy with albendazole and dexamethasone on Th cytokine gene expression in PBMC from patients with eosinophilic meningitis.
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Anti-Inflammatory Agents; C | 2009 |
[Two outbreaks of eosinophilic meningitis in Yunann (China) clinical, epidemiological and therapeutical issues].
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; China; Diet; Disease Outbreaks; Eo | 2009 |
Efficacy of combined treatment with albendazole and baicalein against eosinophilic meningitis induced by Angiostrongylus cantonensis in mice.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Antinematodal Agents; Body Weight; Chemokine CCL1 | 2011 |
Efficacy of albendazole combined with a marine fungal extract (m2-9) against Angiostrongylus cantonensis-induced meningitis in mice.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Behavior, Animal; Body Weight; Dis | 2012 |
Curcumin alleviates eosinophilic meningitis through reduction of eosinophil count following albendazole treatment against Angiostrongylus cantonensis in mice.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; C | 2012 |
The use of albendazole and diammonium glycyrrhizinate in the treatment of eosinophilic meningitis in mice infected with Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Body Weight; Dexamethasone; Diseas | 2013 |
The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Brain; Disease Models, Animal; Eos | 2004 |
Efficacy of albendazole-GM6001 co-therapy against Angiostrongylus cantonensis-induced meningitis in BALB/c mice.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Brain; Drug Combinations; Male; Ma | 2005 |
Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman.
Topics: Albendazole; Animals; Anthelmintics; Chronic Disease; Eosinophilia; Female; Glucocorticoids; Headach | 2006 |
Pathological changes in the brains of rabbits experimentally infected with Angiostrongylus cantonensis after albendazole treatment: histopathological and magnetic resonance imaging studies.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Brain; Choroid Plexus; Encephaliti | 2006 |
Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; C | 2006 |
[Headache after a stay in the Dominican Republic].
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Antibodies, Helminth; Domin | 2006 |
Chinese herbal medicine Yin-Chen-Extract as an adjunct to anthelmintic albendazole used against Angiostrongylus cantonensis-induced eosinophilic meningitis or meningoencephalitis.
Topics: Albendazole; Animals; Anthelmintics; Base Sequence; DNA Primers; Drugs, Chinese Herbal; Interleukin- | 2006 |
Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Antinematodal Agents; Brain; Disease Models, Anim | 2007 |
Full recovery from Baylisascaris procyonis eosinophilic meningitis.
Topics: Albendazole; Anemia, Sickle Cell; Animals; Anthelmintics; Anti-Inflammatory Agents; Ascaridida Infec | 2007 |
Neurological picture. Eosinophilic meningitis and an ocular worm in a patient from Kerala, south India.
Topics: Adult; Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Drug Therapy, Combination; | 2008 |
Racemose neurocysticercosis after chronic meningitis: effect of medical treatment.
Topics: Adult; Albendazole; Chronic Disease; Cysticercosis; Follow-Up Studies; Humans; Magnetic Resonance Im | 1995 |
Eosinophilic meningitis.
Topics: Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Eosinophilia; Female; Helminthiasis; Hu | 1999 |